Abstract
According to the Regulation of Traditional and Complementary Medicine Practices; Apitherapy is defined as complementary usage of honey bee and bee products in prevention and treatment of some diseases. The main bee products are honey, beeswax, bee pollen, propolis, royal jelly, bee venom and their derivatives. Many studies on these products support their potential of health protection. Shortcomings in standardization of the products used in apitherapy are the main factors that cause difficulty in making clinical studies on apitherapy. For the expected positive effect, the products should be of good quality. The related regulation has required chemical analyzes of the products and compliance with certain rules.
References
- 1. Bansal V, Medhi B, Pandhi P. Honey -A remedy rediscovered and its therapeutic utility. Kathmandu Univ Med J. 2005; 3:305–309.
- 2. Crane. E., A short history of knowledge about honey bees (Apis) up to 1800, Bee World, 2004 ; 85(1) : 6–11.
- 3. Da Silva Veiga,P.A. 2004. Health and Medicine in Ancient Egypt: Magic and Science, British Archaeological Reports
- 4. Budge, E.A.W. 1894.The Mummy: Chapters on Egyptian Funereal Archaeology, University Press
- 5. Harissis H.V. and Harissis,A.V. 2009. Apiculture in the Prehistoric Aegean. Minoan and Mycenaean Symbols Revisited. Appendix: Virgil’s Aristaios: An Ancient Beekeeping Educational Myth, British Archaeological Reports S1958
- 6. Geleneksel ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği, 2014. Resmi Gazete, Sayı 29158, 27 Ekim 2014.
- 7. Sforcin J.M.. Propolis and the immune system: a review, Journal of Ethnopharmacology 2007;113, 1-14.
- 8. Orsolic N.. Honey and Cancer, JAAS 2009;1, 93-103.
- 9. Wu G., Li Y., Liu G. The immunoregulative effect of royal jelly acid, Zhongguo Yaoke Daxue Xuebao 1991; 22, 117-118.
- 10. Watanabe K., Shinmoto H., Kobori M., Tsushida T., Shinohara K., Kanaeda J., Yonekura M. Growth stimulation with honey royal jelly DIII protein of human lymphocytic cell lines in a serum-free medium., Biotechnol. Tech. 1996; 10, 959-962.
- 11. Vucevic D., Melliou E., Vasilijic S., Gasic S., Ivanovski P., Chinou I., Colic M. Fatty acids isolated from royal jelly modulate dendritic cell-mediated immune response in vitro, Int. Immunopharmacol. 2007; 7, 1211-1220.
- 12. Abuharfeil N., Al Oran L., Abo-Shehada M. The effects of bee honey on the proliferative activity of human B and T lymphocytes and activity of phagocytes., Food and Agricultural Immunology 2008; 169-177.
- 13. Al-Waili N.S. Effects of daily consumption of honey solution on hematological indices and blood levels of minerals and enzymes in normal individuals, Journal of Medicinal Food 2003; 6, 135-140.
- 14. Banskota A.H., Tezuka Y., Kadota S. Recent progress in pharmacological research of propolis, Phytotherapy Research 2001; 15, 561-571.
- 15. TSE, ICS 65.140 Türk Standardı, TS 3036/Ocak 2010
- 16. Krell, R. 1996. Value-Added Products From Beekeeping, Fao Agricultural Services Bulletin No. 124. Food and Agriculture Organization of the United Nations Rome
- 17. TSE, Türk Satandardı, TS 2906/Aralık 1977
- 18. TSE; ICS 65.140 Türk Standardı, TS 12910/Ocak 2003
- 19. TSE; ICS 65.140 Türk Standardı, TS 10255/Aralık 2006
- 20. TSE; ICS 65.140;67.230 Türk Standardı, TS 6666/Aralık 2000
- 21. TSE; ICS 65.140 Türk Standardı, TS 13126/Ocak 2005
- 22. Geleneksel Ve Tamamlayıcı Tıp Uygulamalarının Klinik Araştırmaları Hakkında Yönetmelik, 2019 Resmi Gazete, Sayı : 30709, 9 Mart 2019
Abstract
Apiterapi,
Geleneksel ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği’nde; arı ve arı
ürünlerinin koruyucu ve bazı hastalıkların tedavisinde destek olarak
kullanılması şeklinde tanımlanmıştır. Başlıca arı ürünleri bal, balmumu, arı
poleni, propolis, arı sütü, arı zehri ve bunların türevleridir. Bu ürünler
üzerine pekçok araştırma “sağlığı koruma” potansiyelini desteklemektedir.
Apiterapide kullanılan ürünlerin standardizasyonu konusundaki eksiklikler apiterapiyle
ilgili klinik çalışmaların yapılabilmesini zorlaştıran temel
etkenlerdendir. Beklenilen olumlu etki için kullanılan ürünün kaliteli olması
şarttır. İlgili yönetmelik, ürünlerde kimyasal analizlerin yapılmış olması ve
belli kurallara uygunluk şartı getirmiştir.
Keywords
References
- 1. Bansal V, Medhi B, Pandhi P. Honey -A remedy rediscovered and its therapeutic utility. Kathmandu Univ Med J. 2005; 3:305–309.
- 2. Crane. E., A short history of knowledge about honey bees (Apis) up to 1800, Bee World, 2004 ; 85(1) : 6–11.
- 3. Da Silva Veiga,P.A. 2004. Health and Medicine in Ancient Egypt: Magic and Science, British Archaeological Reports
- 4. Budge, E.A.W. 1894.The Mummy: Chapters on Egyptian Funereal Archaeology, University Press
- 5. Harissis H.V. and Harissis,A.V. 2009. Apiculture in the Prehistoric Aegean. Minoan and Mycenaean Symbols Revisited. Appendix: Virgil’s Aristaios: An Ancient Beekeeping Educational Myth, British Archaeological Reports S1958
- 6. Geleneksel ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği, 2014. Resmi Gazete, Sayı 29158, 27 Ekim 2014.
- 7. Sforcin J.M.. Propolis and the immune system: a review, Journal of Ethnopharmacology 2007;113, 1-14.
- 8. Orsolic N.. Honey and Cancer, JAAS 2009;1, 93-103.
- 9. Wu G., Li Y., Liu G. The immunoregulative effect of royal jelly acid, Zhongguo Yaoke Daxue Xuebao 1991; 22, 117-118.
- 10. Watanabe K., Shinmoto H., Kobori M., Tsushida T., Shinohara K., Kanaeda J., Yonekura M. Growth stimulation with honey royal jelly DIII protein of human lymphocytic cell lines in a serum-free medium., Biotechnol. Tech. 1996; 10, 959-962.
- 11. Vucevic D., Melliou E., Vasilijic S., Gasic S., Ivanovski P., Chinou I., Colic M. Fatty acids isolated from royal jelly modulate dendritic cell-mediated immune response in vitro, Int. Immunopharmacol. 2007; 7, 1211-1220.
- 12. Abuharfeil N., Al Oran L., Abo-Shehada M. The effects of bee honey on the proliferative activity of human B and T lymphocytes and activity of phagocytes., Food and Agricultural Immunology 2008; 169-177.
- 13. Al-Waili N.S. Effects of daily consumption of honey solution on hematological indices and blood levels of minerals and enzymes in normal individuals, Journal of Medicinal Food 2003; 6, 135-140.
- 14. Banskota A.H., Tezuka Y., Kadota S. Recent progress in pharmacological research of propolis, Phytotherapy Research 2001; 15, 561-571.
- 15. TSE, ICS 65.140 Türk Standardı, TS 3036/Ocak 2010
- 16. Krell, R. 1996. Value-Added Products From Beekeeping, Fao Agricultural Services Bulletin No. 124. Food and Agriculture Organization of the United Nations Rome
- 17. TSE, Türk Satandardı, TS 2906/Aralık 1977
- 18. TSE; ICS 65.140 Türk Standardı, TS 12910/Ocak 2003
- 19. TSE; ICS 65.140 Türk Standardı, TS 10255/Aralık 2006
- 20. TSE; ICS 65.140;67.230 Türk Standardı, TS 6666/Aralık 2000
- 21. TSE; ICS 65.140 Türk Standardı, TS 13126/Ocak 2005
- 22. Geleneksel Ve Tamamlayıcı Tıp Uygulamalarının Klinik Araştırmaları Hakkında Yönetmelik, 2019 Resmi Gazete, Sayı : 30709, 9 Mart 2019
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Clinical Sciences (Other) |
| Journal Section | Review |
| Authors | |
| Publication Date | September 30, 2019 |
| Acceptance Date | August 8, 2019 |
| Published in Issue | Year 2019 GETAT Special Issue |
Dergimiz Uluslararası hakemli bir dergi olup TÜRKİYE ATIF DİZİNİ, TürkMedline, CrossREF, ASOS index, Google Scholar, JournalTOCs, Eurasian Scientific Journal Index(ESJI), SOBIAD ve ISIindexing dizinlerinde taranmaktadır. TR Dizin(ULAKBİM), SCOPUS, DOAJ için başvurularımızın sonuçlanması beklenmektedir.